|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
14.130 +0.340 (+2.466%) Non-current Assets
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | 13,402 | -1.802% | 13,648 | 14,141 | 14,634 | 15,127 |
| Property, plant, equip. & others | 815,883 | 1.454% | 804,190 | 797,581 | 739,056 | 746,213 |
| Land & other Lease Assets | 112,395 | -3.923% | 116,984 | 127,959 | 124,652 | 128,786 |
| Intangible Assets | 263,946 | -0.626% | 265,608 | 268,960 | 283,140 | 311,904 |
| Interests in Asso. & JCEs | 32,802 | -1.605% | 33,337 | 9,934 | 0 | 0 |
| Other Non-current Assets | 927,599 | 62.310% | 571,498 | 83,194 | 68,432 | 67,679 |
| 2,166,027 | 19.984% | 1,805,265 | 1,301,769 | 1,229,914 | 1,269,709 | |
Current Assets
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | 234,694 | -13.526% | 271,405 | 289,677 | 367,087 | 276,080 | |
| Trade Receivables | 291,839 | -5.160% | 307,718 | 297,573 | 255,838 | 259,562 | |
| Cash & Bank Balances | 1,268,932 | 2.799% | 1,234,384 | 2,907,682 | 2,748,262 | 2,450,173 | |
| Other Current Assets | 2,870,181 | 2.828% | 2,791,251 | 1,056,381 | 906,893 | 636,856 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 4,665,646 | 1.322% | 4,604,758 | 4,551,313 | 4,278,080 | 3,622,671 | ||
Current Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | 130,443 | -0.046% | 130,503 | 75,643 | 83,098 | 59,891 | ||
| S-T Debt & Leases | 227,418 | 8.445% | 209,709 | 259,763 | 507,636 | 454,229 | ||
| Other Current Liabilities | 1,246,115 | 14.311% | 1,090,105 | 1,035,394 | 904,262 | 836,368 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 1,603,976 | 12.141% | 1,430,317 | 1,370,800 | 1,494,996 | 1,350,488 | |||
| Net Current Assets | 3,061,670 | -3.552% | 3,174,441 | 3,180,513 | 2,783,084 | 2,272,183 | ||
| Total Assets Less Current Liabilities | 5,227,697 | 4.980% | 4,979,706 | 4,482,282 | 4,012,998 | 3,541,892 | ||
Non-current Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | 2,058 | -35.908% | 3,211 | 7,406 | 3,898 | 5,947 | |||
| Other Non-current Liabilities | 163,928 | 18.253% | 138,625 | 81,824 | 90,388 | 96,940 | |||
| 165,986 | 17.027% | 141,836 | 89,230 | 94,286 | 102,887 | ||||
Capital and Reserves
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | 66,607 | -0.921% | 67,226 | 67,308 | 63,812 | 63,450 | ||||
| Reserves | 4,694,335 | 5.070% | 4,467,807 | 4,030,295 | 3,562,691 | 3,081,689 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 4,760,942 | 4.981% | 4,535,033 | 4,097,603 | 3,626,503 | 3,145,139 | ||||
| Non-controlling Interests | 300,769 | -0.683% | 302,837 | 295,449 | 292,209 | 293,866 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 5,061,711 | 4.627% | 4,837,870 | 4,393,052 | 3,918,712 | 3,439,005 | |||||
Commitments and Contingent Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | -- | 493,985 | 532,903 | 450,758 |
| Contingent Liabilities | -- | -- | -- | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 595,309 |
| %Change | 19.468% |
| EPS / (LPS) | RMB 0.710 |
| NBV Per Share (¥) | RMB 5.674 |